FGFR3 and urinary bladder neoplasm: It should be noted that a high proportion of bladder tumors present a wild-type phenotype (no FGFR3 or TP53 mutations): 32% of Ta tumors, 40% of T1 tumors and 43% of T2-4 tumors).